Multiple Sclerosis in Iran

Document Type: Review article


1 Cellular and Molecular Research Center, , Basic Health Sciences Institute, Shahrekord University of Medical Science, Shahrekord, Iran

2 Social Determinants of Health Research Center, Shahrekord University of Medical Science, Shahrekord, Iran


Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS). This highly
disabling disorder is characterized by a variable clinical course. MS is a heterogeneous disease with a
complex pathology and significant social and economic impact. MS is associated with dysfunction of
parts of the nervous system which results in a range of signs and symptoms, including physical, mental,
and sometimes psychiatric problems. There is no definite treatment for MS. Iran has been thought
to be located in the low risk zone of MS prevalence. However, recent studies and investigations in
some cities such as Isfahan, a central province of Iran, have suggested a medium-to-high risk level
of MS prevalence. Pathophysiological processes in MS contribute to the disease course and clinical
manifestations. Therefore, biomarkers that are indicators of these events would provide significant
potential for diagnosis, prediction of disease course, and optimization of therapeutic responses. This
review provides information on the prevalence of MS and some risk factors among Iranian people.


Main Subjects